Professional Documents
Culture Documents
Strategi Pengendalian:
Hasil Capaian dan Target ke Depan
ANTIBIOTIC ERA
60-80%
KPMG LLP - December 2014
NATIONAL PROBLEM OF
ANTIMICROBIAL RESISTANCE
Indonesia ada dimana: ??
NAP-AMR
1.
Improve awareness and understanding of
antimicrobial resistance through effective
communication, education and training
Indonesia: ???
REGULASI , PELATIHAN DAN
DUKUNGAN
BAKTERI
RESISTEN
MISUSE /
OVERUSE
• Resistance is
unresponsiveness
to antimicrobial
agents in standard
doses TRANSMISION
GLOBAL ACTION
PLAN ON AMR
1. Improve awareness and understanding of AMR through effective
communication, education and training.
2. Strengthen the knowledge and evidence base through research
and surveillance.
3. Reduce the incidence of infection through effective hygiene and
infection prevention measures.
4. Optimize the use of antimicrobial medicines in human and animal
health. Bagaimana Indonesia: ??
5. Develop the economic case for sustainable investment that takes
account of the needs of all countries, as well as the case for
investment in new medicines, diagnostic tools, vaccines and other
interventions.
KOMITE PENGENDALIAN RESISTENSI ANTIMIKROBA
KEMENTERIAN KESEHATAN
AMU SURVEILLANCE
ANTIBIOTIC QUALITATIVE ANALISIS
6 TEACHING HOSPITALS - 2016
100
100
OBGYN SURGICAL
80 80
60 60
40 40
20 20
0 0
0 I II III A IV V VI 0 I II III IV V VI
RS A RS B RS C RS D RS E RS F RS A RS B RS C RS D RS E RS F
40 40
35 WHO/
PPRA ESBL
30 28 26-56%
20 RSDS RSDS
10 9 AMRIN
0
2000 2005 2010 2013 2016
GLOBAL ACTION
PLAN ON AMR
1. Improve awareness and understanding of AMR through effective
communication, education and training.
2. Strengthen the knowledge and evidence base through research
and surveillance.
3. Reduce the incidence of infection through effective hygiene and
infection prevention measures.
4. Optimize the use of antimicrobial medicines in human and animal
health.
5. Develop the economic case for sustainable investment that takes
account of the needs of all countries, as well as the case for
investment in new medicines, diagnostic tools, vaccines and other
interventions.
KOMITE PENGENDALIAN RESISTENSI ANTIMIKROBA
KEMENTERIAN KESEHATAN
MORBIDITAS & MORTALITAS
USA
23.000
• HAI > 30% 300 juta
• 40-60% Thailland
preventable 38.000
70 juta
• MDRO INA
135.000
Lyons, WHRA, 2010) 256 juta
• Kegagalan terapi.
• Kegagalan operasi
canggih, kompleks
• menimbulkan beban
morbiditas, mortalitas,
kecacatan
• COST
GLOBAL ACTION
PLAN ON AMR
1. Improve awareness and understanding of AMR through effective
communication, education and training.
2. Strengthen the knowledge and evidence base through research
and surveillance.
3. Reduce the incidence of infection through effective hygiene and
infection prevention measures.
4. Optimize the use of antimicrobial medicines in human and animal
health.
5. Develop the economic case for sustainable investment that takes
account of the needs of all countries, as well as the case for
investment in new medicines, diagnostic tools, vaccines and other
interventions.
KOMITE PENGENDALIAN RESISTENSI ANTIMIKROBA
KEMENTERIAN KESEHATAN
SELECTIVE PRESSURE
FAKTA PENGUNAAN
ANTIBIOTIK DI RS
Hasil
Kategori
Sby Semg
(%) (%)
Tidak ada
indikasi 76 53
terapi
Tidak ada
indikasi 55 81
profilaksis
• HAI di RS meningkat.
• Banyak dokter tidak tepat menggunakan
antibiotik 50-80%
• Reservoir bakteri resisten – 62% (50-82)ESBL
• Mortalitas meningkat
GLOBAL ACTION
PLAN ON AMR
1. Improve awareness and understanding of AMR through effective
communication, education and training.
2. Strengthen the knowledge and evidence base through research
and surveillance.
3. Reduce the incidence of infection through effective hygiene and
infection prevention measures.
4. Optimize the use of antimicrobial medicines in human and animal
health.
5. Develop the economic case for sustainable investment that takes
account of the needs of all countries, as well as the case for
investment in new medicines, diagnostic tools, vaccines and other
interventions.
KOMITE PENGENDALIAN RESISTENSI ANTIMIKROBA
KEMENTERIAN KESEHATAN
CORE PLAN DI RUMAH SAKIT
• PNPK/PPG/CP
• ASP
• DALIN TRANSMISI AB • REVIEW
• CUCI TANGAN • HE AB
• ISOLASI RESTRICTION
HARAPAN Turunnya Prevalensi Bakteri
Penghasil ESBL Nasional
70
60 60
50
presentage
40 40 40
35 ESBL
30
28 25
20
10 9
0
2000 2005 2010 2013 2016 2018 2020
HARAPAN: Peresepan Antibiotik Di
Kalangan Klinisi Semakin bijak
HARAPAN Healthcare-
Associated Infection Semakin
Turun (25%)
HARAPAN
HIGH QUALITY HEALTH CARE
Cases
save
ALOS
Beaya
Prosedur/ICU
tenaga/waktu
unsafe Morbiditas
antibiotic Mortalitas
Medikolegal
PPRA bukan Revenue Centre, tetapi
Cost Saving
TERIMA
KASIH